Your browser doesn't support javascript.
loading
ERAP2 is associated with ankylosing spondylitis in HLA-B27-positive and HLA-B27-negative patients.
Robinson, Philip C; Costello, Mary-Ellen; Leo, Paul; Bradbury, Linda A; Hollis, Kelly; Cortes, Adrian; Lee, Seunghun; Joo, Kyung Bin; Shim, Seung-Cheol; Weisman, Michael; Ward, Michael; Zhou, Xiaodong; Garchon, Henri-Jean; Chiocchia, Gilles; Nossent, Johannes; Lie, Benedicte A; Førre, Øystein; Tuomilehto, Jaakko; Laiho, Kari; Jiang, Lei; Liu, Yu; Wu, Xin; Elewaut, Dirk; Burgos-Vargas, Ruben; Gensler, Lianne S; Stebbings, Simon; Haroon, Nigil; Mulero, Juan; Fernandez-Sueiro, Jose Luis; Gonzalez-Gay, Miguel A; Lopez-Larrea, Carlos; Bowness, Paul; Gafney, Karl; Gaston, John S Hill; Gladman, Dafna D; Rahman, Proton; Maksymowych, Walter P; Xu, Huji; van der Horst-Bruinsma, Irene E; Chou, Chung-Tei; Valle-Oñate, Raphael; Romero-Sánchez, María Consuelo; Hansen, Inger Myrnes; Pimentel-Santos, Fernando M; Inman, Robert D; Martin, Javier; Breban, Maxime; Evans, David; Reveille, John D; Kim, Tae-Hwan.
Afiliação
  • Robinson PC; Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Costello ME; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Leo P; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Bradbury LA; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Hollis K; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Cortes A; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • Lee S; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
  • Joo KB; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
  • Shim SC; Department of Medicine, Division of Rheumatology, Eulji University Hospital, Daejeon, Republic of Korea.
  • Weisman M; Department of Medicine/Rheumatology, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Ward M; National Institute of Arthritis and Musculoskeletal and Skin Diseases, US National Institutes of Health, Bethesda, Maryland, USA.
  • Zhou X; Department of Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Garchon HJ; INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Laboratoire d'Excellence INFLAMEX, France Genetics Division, Ambroise Paré Hospital (AP-HP), Boulogne-Billancourt, Paris, France.
  • Chiocchia G; INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Laboratoire d'Excellence INFLAMEX, France.
  • Nossent J; School of Medicine, University of Western Australia, Western Australia, Perth, Australia Department of Rheumatology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • Lie BA; Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway Department of Immunology, Oslo University Hospital, Oslo, Norway.
  • Førre Ø; Department of Rheumatology, University Hospital Oslo, Oslo, Norway.
  • Tuomilehto J; Centre for Vascular Prevention, Danube-University Krems, Krems, Austria. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland King Abdulaziz University, Jeddah, Saudi Arabia.
  • Laiho K; Department of Medicine, Päijät-Häme Central Hospital, Lahti, Finland.
  • Jiang L; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Liu Y; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Wu X; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • Elewaut D; Department of Rheumatology, Ghent University Hospital, Ghent, Belgium VIB Inflammation Research Center, Ghent, Belgium.
  • Burgos-Vargas R; Department of Rheumatology, Faculty of Medicine, Hospital General de México, Universidad Nacional Autónoma de México, Mexico City, México.
  • Gensler LS; University of California, San Francisco, California, USA.
  • Stebbings S; Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
  • Haroon N; Division of Rheumatology, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Mulero J; Rheumatology Department, Hospital Puerta de Hierro, Madrid, Spain.
  • Fernandez-Sueiro JL; Rheumatology Department, Complejo Hospitalario La Coruña, Instituto de Investigación Biomédica A Coruña (INIBIC), La Coruña, Spain.
  • Gonzalez-Gay MA; Rheumatology Department, Hospital Marqués de Valcecilla, Instituto de Formación e Investigación Marqués de Valcecillas (IFIMAV), Santander, Spain.
  • Lopez-Larrea C; Department of Immunology, Asturias Central University Hospital, Oviedo, Spain Fundación Renal Iñigo Alvarez de Toledo, Madrid, Spain.
  • Bowness P; National Institute for Health Research (NIHR) Oxford Musculoskeletal Biomedical Research Unit, Nuffield Orthopaedic Centre, Oxford, UK.
  • Gafney K; Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK.
  • Gaston JS; Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Gladman DD; Division of Rheumatology, University of Toronto, Toronto, Ontario, Canada Toronto Western Research Institute, Toronto, Ontario, Canada Psoriatic Arthritis Program, University Health Network, Toronto, Ontario, Canada.
  • Rahman P; Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
  • Maksymowych WP; Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Xu H; Department of Rheumatology and Immunology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
  • van der Horst-Bruinsma IE; Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands.
  • Chou CT; Department of Medicine, Division of Allergy, Immunology, Rheumatology, Taipei Veterans General Hospital, Taipei, Taiwan. School of Medicine, National Yang- Ming University, Taipei, Taiwan.
  • Valle-Oñate R; SpA Group Hospital Militar, Universidad Militar Nueva Granada, Bogotá, Colombia.
  • Romero-Sánchez MC; SpA Group Hospital Militar, Universidad Militar Nueva Granada, Bogotá, Colombia.
  • Hansen IM; Helgelandssykehuset, Mo i Rana, Norway.
  • Pimentel-Santos FM; Chronic Diseases Research Centre (CEDOC), Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal.
  • Inman RD; Division of Rheumatology, Toronto Western Hospital, Toronto, Ontario, Canada.
  • Martin J; Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Granada, Spain.
  • Breban M; INSERM U1173, UFR Simone Veil, Versailles-Saint-Quentin University, Laboratoire d'Excellence INFLAMEX, France Division of Rheumatology, Ambroise Paré Hospital, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, Paris, France.
  • Evans D; The University of Queensland Diamantina Institute, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia MRC Integrative Epidemiology Unit, University of Bristol, UK School of Social and Community Medicine, University of Bristol, Bristol, UK.
  • Reveille JD; Department of Rheumatology and Clinical Immunogenetics, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Kim TH; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.
Ann Rheum Dis ; 74(8): 1627-9, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25917849
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antígeno HLA-B27 / Aminopeptidases Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Antígeno HLA-B27 / Aminopeptidases Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Austrália